Discoveries


Recent Discoveries Stories

Researchers at Moffitt Cancer Center have discovered a triple immunotherapy that may shrink tumors in treatment-resistant melanoma. By blocking three key immune checkpoints—PD-1, LAG-3, and TIM-3—this approach revived the immune system and led to tumor regression in lab models. The findings could lead to new second-line treatments for patients who don’t respond to current therapies.
New triple immunotherapy could help melanoma patients who fail standard treatments, Moffitt Cancer Center study finds.
Joshua Shavit